Insider Transactions in Q2 2024 at Immix Biopharma, Inc. (IMMX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2024
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
2,600
+0.23%
|
$5,200
$2.13 P/Share
|
|
Jun 07
2024
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
2,500
+0.87%
|
$5,000
$2.12 P/Share
|
|
Jun 04
2024
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
3,300
+0.29%
|
$3,300
$1.81 P/Share
|
|
Jun 04
2024
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
3,300
+1.15%
|
$3,300
$1.81 P/Share
|
|
May 20
2024
|
Gabriel S Morris CFO |
BUY
Grant, award, or other acquisition
|
Indirect |
48,282
+29.09%
|
-
|
|
May 20
2024
|
Gabriel S Morris CFO |
BUY
Grant, award, or other acquisition
|
Direct |
194,218
+40.95%
|
-
|
|
May 20
2024
|
Magda Marquet Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,155
+31.46%
|
-
|
|
May 20
2024
|
Melissa Jane Buchan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,127
+4.78%
|
-
|
|
May 20
2024
|
Ilya M Rachman CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
218,359
+16.19%
|
-
|
|
May 20
2024
|
Helen C. Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
74,241
+29.82%
|
-
|
|
May 15
2024
|
Magda Marquet Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,002
+50.0%
|
-
|
|
May 15
2024
|
Melissa Jane Buchan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,332
+5.88%
|
-
|
|
May 15
2024
|
Helen C. Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
87,740
+46.55%
|
-
|
|
May 14
2024
|
Ilya M Rachman CEO and Chairman |
BUY
Open market or private purchase
|
Direct |
4,300
+0.47%
|
$8,600
$2.25 P/Share
|
|
May 14
2024
|
Gabriel S Morris CFO |
BUY
Open market or private purchase
|
Direct |
4,500
+4.98%
|
$9,000
$2.23 P/Share
|